The number of people who tested positive for COVID-19 in France rose by 23,996 in the past 24 hours, according to figures released by the country's Public Health Agency on Saturday.
The daily tally of new cases, down from Friday's 25,207, has brought the cumulative number of infections to 3,736,016. The country's death toll rose by 186 in a 24-hour span to 86,332.
So far, a total of 2,917,925 people in France have been inoculated, of whom 1,560,575 have received the two doses, representing 2.33 percent of the country's population, health authorities' data showed.
France has already received over 7.7 million COVID-19 vaccine doses developed by Pfizer/BioNTech, Moderna, and AstraZeneca.
As the world is struggling to contain the pandemic, vaccination is underway in some countries with the already-authorized coronavirus vaccines.
Meanwhile, 255 candidate vaccines are still being developed worldwide -- 73 of them in clinical trials -- in countries including Germany, China, Russia, Britain, and the United States, according to the latest information released by the World Health Organization.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)